Related references
Note: Only part of the references are listed.Tumor-infiltrating lymphocyte response in cutaneous melanoma in the elderly predicts clinical outcomes
Travis E. Grotz et al.
MELANOMA RESEARCH (2013)
Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma
Trine O. Jensen et al.
CANCER (2012)
An immune-active tumor microenvironment favors clinical response to ipilimumab
Rui-Ru Ji et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Population-Based 20-Year Survival Among People Diagnosed With Thin Melanomas in Queensland, Australia
Adele C. Green et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Tumor-Infiltrating Lymphocyte Grade Is an Independent Predictor of Sentinel Lymph Node Status and Survival in Patients With Cutaneous Melanoma
Farhad Azimi et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
Janis M. Taube et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
AJCC melanoma staging update: impact on dermatopathology practice and patient management
Adriano Piris et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2011)
Tumor Location Predicts Survival in Cutaneous Head and Neck Melanoma
Warren H. Tseng et al.
JOURNAL OF SURGICAL RESEARCH (2011)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Presence of Tumor-infiltrating Lymphocytes and a Dominant Nodule Within Primary Melanoma Are Prognostic Factors for Relapse-Free Survival of Patients With Thick (T4) Primary Melanoma
Uma N. M. Rao et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2010)
2010 TNM Staging System for Cutaneous MelanomaaEuro¦and Beyond
Jeffrey E. Gershenwald et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Gene Signature in Melanoma Associated With Clinical Activity A Potential Clue to Unlock Cancer Immunotherapy
Thomas F. Gajewski et al.
CANCER JOURNAL (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: Outcome analysis from a single-institution prospectively collected database
M. Mandala et al.
EUROPEAN JOURNAL OF CANCER (2009)
Final Version of 2009 AJCC Melanoma Staging and Classification
Charles M. Balch et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the surveillance, epidemiology, and end results (SEER) program
Anne M. Lachiewicz et al.
ARCHIVES OF DERMATOLOGY (2008)
Innate immunity and aging
Christian R. Gomez et al.
EXPERIMENTAL GERONTOLOGY (2008)
Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression
Inge S. van Houdt et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma
Rebecca C. Taylor et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
NRAS and BRAF mutations in melanoma turnours in re ation to clinical characteristics:: a study based on mutation screening by pyrosequencing
Esther Edlundh-Rose et al.
MELANOMA RESEARCH (2006)
A design for cancer case-control studies using only incident cases: experience with the GEM study of melanoma
Colin B. Begg et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2006)
Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma Study
RC Millikan et al.
CARCINOGENESIS (2006)
Share Paper
